Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Pharma Firms To Face Periodic Inspection As HC Flags Effluent Risks

Court slaps over Rs 1 crore fine on Elder Pharma

Farhat Nasim5 Feb 2025 1:13 PM IST

Mumbai: Elder Pharmaceuticals Ltd. has been slapped a fine of Rs 1.83 crore for dishonoring a cheque. A Magistrate Court in Mumbai found the company...

Court Grants Relief to PG Medical Students, Permits Delayed Joining as Assistant Surgeons

Madras HC slams NMC for terming Gender Identity a 'Disorder' in CBME curriculum

Farhat Nasim4 Feb 2025 9:30 AM IST

Chennai: The Madras High Court has severely condemned the National Medical Commission (NMC) for its continued use of the term 'Gender Identity...

36 Essential Drugs Become Cheap with Budget 2025, See Full List

Farhat Nasim1 Feb 2025 5:56 PM IST

New Delhi: Finance Minister Nirmala Sitharaman announced on Saturday that 36 life-saving drugs will be fully exempt from Basic Customs Duty (BCD)...

Himachal to develop medical device park independently

Union Budget 2025 Disappoints Medical Devices Industry, No Relief for Import Dependency: AiMed

Farhat Nasim1 Feb 2025 3:05 PM IST

New Delhi: The Union Budget 2025 has laid out a strong macro-economic and policy direction, but it has left the medical devices industry disheartened...

Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 Strengths

Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller

Farhat Nasim29 Jan 2025 8:04 PM IST

Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received approval from the U.S....

NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP Uniformity

Drug Price Transparency: Committee Asks NPPA To Rollout PMRU In Remaining States, UTs

Farhat Nasim28 Jan 2025 7:04 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has been asked by the Parliamentary Standing Committee on Chemicals and Fertilisers to...

No Eligible Successor: Centre Clarifies DCGIs Contractual Reappointment

Dr Raghuvanshi To Continue as DCGI Amidst Search For Successor, 18 Candidates Vie For Top Post

Farhat Nasim25 Jan 2025 6:28 PM IST

New Delhi: As the government continues its search for a new Drugs Controller General of India (DCGI), it has decided to extend the tenure of the...

Corporate Chaos: Glenmark Faces Backlash Over Abrupt Job Cuts

Farhat Nasim24 Jan 2025 5:31 PM IST

New Delhi: Enraged after the alleged abrupt layoff citing redundancy, hundreds of employees of Glenmark Pharmaceuticals' Consumer Care Division, which...

Granules recalls over 33000 bottles BP medication in US

Zydus Lifesciences Dapsone Gel Recalled by USFDA

Farhat Nasim23 Jan 2025 7:49 PM IST

New Delhi: Zydus Lifesciences Ltd has been implicated in a recall of 23,304 bottles of Dapsone Gel 7.5%, a popular acne treatment distributed under...

NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details

NPPA Directs Drug Makers to Submit Data for Ceiling Prices of Lohexol, IV Fluids

Farhat Nasim23 Jan 2025 7:46 PM IST

New Delhi: The National Pharmaceuticals Pricing Authority (NPPA) has sought certain data from concerned drug manufacturers and marketing...

Last Chance: PCI Extends Deadline for 2025-26 Academic Year Approvals

Farhat Nasim22 Jan 2025 6:07 PM IST

New Delhi: The Pharmacy Council of India (PCI) has extended the deadline for institutions to submit their Standard Inspection Format (SIF)...

Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute

Macleods Pharma Wins Legal Battle Over Linagliptin Patent

Farhat Nasim21 Jan 2025 5:41 PM IST

New Delhi: In a major setback to Boehringer Ingelheim, the Delhi High Court has upheld the maintainability of a revocation petition filed by...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok